Ford is recalling just under 100,000 versions of the 2018-2020 F-150 pick-up truck for a second time. After not being ...

Watch a subscriber-only discussion exploring longevity's new focus. Available only for MIT Alumni and subscribers. Listen to the session or watch below Billions of dollars are flooding into efforts to ...

Ford is recalling more than 741,000 vehicles in the U.S. because a transmission issue may damage the park system, which could increase the risk of a crash or injury.

Ford's battle with quality control shows no signs of slowing down. Just a year after shattering records for the most automotive recalls ever issued in a single calendar year, the Blue Oval is pacing ...

Ford Motor Co. took an unusually human approach to fixing its stubborn quality problems: It brought back what it calls “gray beard” engineers to help train younger staff and to reprogram the ...

Ford's AI quality control experiment failed — and it took three years to fix. The automaker rehired 350 veteran engineers after automated systems couldn't catch critical defects. That decision paid ...

Ford made a grave mistake with AI, and has learned the hard way what happens when you overcommit to the technology without properly training it — alienating top talent in the process. The automaker ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Ford executives said they have hired 350 veteran engineers — some of them were former employees, while others had been working at suppliers — after artificial intelligence and automated systems failed ...

The automaker was recently named No. 1 in JD Power’s initial quality ranking for the first time in 16 years. The automaker was recently named No. 1 in JD Power’s initial quality ranking for the first ...

Here’s what you’ll learn when you read this story: Modern glaucoma treatments can only preserve a patient’s current level of vision, offering no hope of restoration. A new Phase 1 clinical trial is ...